Target intelligence / Profile preview

Supervillin family member 2, pseudogene (SVIL2P)

Target
SVIL2P
Molecular classification
Other (Pseudogene)
01

Overview

Supervillin family member 2, pseudogene (SVIL2P) is classified as a pseudogene related to the supervillin gene family. Pseudogenes are non-functional DNA sequences derived from ancestral genes; they generally do not encode functional protein products. While some pseudogenes in the human genome may have regulatory roles—such as generating small RNAs or influencing gene expression by serving as decoys for microRNAs—SVIL2P does not encode a protein and has no known biological activity or established involvement in human disease or clinical pharmacology. Its only reported aliases are SVIL2P and SVILP1, and it resides in the genome as a non-coding sequence[4][3][6].\n\nKey points:\n- SVIL2P is not a receptor, enzyme, transporter, transcription factor, or any other classical drug target.\n- It is a pseudogene, a non-functional genomic remnant.\n- There is no evidence SVIL2P is involved in disease or therapy; it is not studied as a drug target or biomarker[4][6].

Other names
SVILP1
02

Biological functions

Other (Pseudogenes may sometimes affect gene regulation via generation of regulatory small RNAs or via insertional mutagenesis, but SVIL2P does not have reported canonical biological functions)
03

Disease associations

Other (Pseudogene involvement in disease is typically limited to regulatory disruptions, e.g., via epigenetic mechanisms, gene fusion, or miRNA competition, but no disease associations are reported for SVIL2P)

Beyond the preview

Go deeper on Supervillin family member 2, pseudogene (SVIL2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supervillin family member 2, pseudogene (SVIL2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call